(NASDAQ: XRAY) Dentsply Sirona's forecast annual revenue growth rate of 1.42% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.91%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.68%.
Dentsply Sirona's revenue in 2025 is $3,719,000,000.On average, 9 Wall Street analysts forecast XRAY's revenue for 2025 to be $727,694,684,361, with the lowest XRAY revenue forecast at $720,047,000,005, and the highest XRAY revenue forecast at $734,316,406,371. On average, 9 Wall Street analysts forecast XRAY's revenue for 2026 to be $747,993,911,384, with the lowest XRAY revenue forecast at $733,977,607,617, and the highest XRAY revenue forecast at $763,054,512,488.
In 2027, XRAY is forecast to generate $774,771,568,472 in revenue, with the lowest revenue forecast at $754,923,342,380 and the highest revenue forecast at $790,297,918,218.